Your liver is amazing-it just keeps going and going! It is responsible for over 500 vital functions, including regulating blood levels, removing toxins, and balancing and creating nutrients for the rest of the body. #get2knowyourliver@LiverSaver@VCU_Liver@BAREInc_org@liverUSA
#SoberOctober has started! Though you don’t need a designated month to take a break from drinking, this is a great time to reflect on why you drink and how it impacts your life. Check back in a month to share any positive changes.
I was honored to participate in the CLS/CIRM Cell & Gene Therapy Workshop today, along with David Miklos, Phil Cyr, and Geoff Lomax. Lots of great questions, great discussion, and great connections made! #CLS#CIRM#CellTherapy#GeneTherapy
Congratulations Columbia University, Mayo Clinic, and collaborators on the new ARPA-H ‘IndiPHARM’ award to uncover why medicines for metabolic diseases, such as obesity, work for some people and not others. https://t.co/5dzXRM722l
4/8
@hepatx announced it has entered into a collaboration with the @MayoClinic to advance cell therapies to treat liver disease.
https://t.co/ORpWLnurQS
@MayoClinic and @hepatx are collaborating with the goal of developing and evaluating new therapies for liver diseases. Initial efforts will focus on alcohol-related hepatitis.
https://t.co/HmHFzavIuJ
#collaboration#healthcare
🚨 𝗕𝗥𝗘𝗔𝗞𝗜𝗡𝗚 𝗡𝗘𝗪𝗦! 📣
We are super excited to announce that we have entered into a 𝗹𝗶𝗰𝗲𝗻𝘀𝗲 𝗮𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁 𝘄𝗶𝘁𝗵 𝗠𝗮𝘆𝗼 𝗖𝗹𝗶𝗻𝗶𝗰 to advance HepaTx’s innovative stem cell technology into clinical trials! 👏 Great time ahead!
https://t.co/GQ5rvk5gXV
#Alcohol remains one of the leading causes of preventable #deaths in the U.S. Every year, more people die of alcohol-related causes than #drug overdoses. 😮 😱
Problems with alcohol have largely been overlooked.
Watch the video ⬇
https://t.co/7Kf3aSefD9
Let the countdown begin! Only 3 days left until #TLM23. Get ready to immerse yourself in the most amazing #hepatology event of the year. 😃 Start building your schedule: https://t.co/EcpL4JxWBE
Durect's larsucosterol didn't hit it's primary endpoint in the Phase 2b AHFIRM Trial in alcohol-related hepatitis. Numerical improvement in survival, trends in the right direction, but beat up by investors anyways. #liverdisease https://t.co/7gO0ZuajEf
#liverdisease#alcohol
🚨 New Study Alert 🚨 Eating ultra-processed foods puts your liver at risk! 😱 A recent study warns of the dangers lurking in our diets. Let's make healthier choices for our liver's sake. 🍏🥦💚 #HealthyEating#LiverHealth#WellnessMatters#awarness
https://t.co/pjqLFHSGS3